401k Plan data: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN plan

GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 401k Plan overview

Plan Name	GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN
Plan identification number	523

GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN Benefits

401k Plan Type	Welfare Benefit
Plan Features/Benefits	Severance pay Unfunded, fully insured, or combination unfunded/insured welfare plan that will not file a Form 5500 for next plan year pursuant to 29 CFR 2520.104-20.

401k Sponsoring company profile

GENENTECH, INC. has sponsored the creation of one or more 401k plans.

Company Name: GENENTECH, INC.

Employer identification number (EIN): 942347624

NAIC Classification: 325410

Form 5500 Filing Information

Submission information for form 5500 for 401k plan GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
523 2016-01-01 ROBERT WONG
523 2015-01-01 ROBERT WONG
523 2015-01-01 ROBERT WONG
523 2014-01-01 ROBERT ANDREATTA
523 2013-01-01 ROBERT ANDREATTA ROBERT ANDREATTA 2014-10-09
523 2012-01-01 ROBERT ANDREATTA ROBERT ANDREATTA 2013-10-04
523 2011-01-01 ROBERT ANDREATTA ROBERT ANDREATTA 2012-10-10

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
523	2016-01-01	ROBERT WONG
523	2015-01-01	ROBERT WONG
523	2015-01-01	ROBERT WONG
523	2014-01-01	ROBERT ANDREATTA
523	2013-01-01	ROBERT ANDREATTA	ROBERT ANDREATTA	2014-10-09
523	2012-01-01	ROBERT ANDREATTA	ROBERT ANDREATTA	2013-10-04
523	2011-01-01	ROBERT ANDREATTA	ROBERT ANDREATTA	2012-10-10

Plan Statistics for GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN

401k plan membership statisitcs for GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN

Measure Date Value
2016: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 1
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 0
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 0
Total of all active and inactive participants 2016-01-01 0
2015: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 14,432
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 0
Number of retired or separated participants receiving benefits 2015-01-01 1
Number of other retired or separated participants entitled to future benefits 2015-01-01 0
Total of all active and inactive participants 2015-01-01 1
2014: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 13,873
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 14,373
Number of retired or separated participants receiving benefits 2014-01-01 59
Number of other retired or separated participants entitled to future benefits 2014-01-01 0
Total of all active and inactive participants 2014-01-01 14,432
2013: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 12,355
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 13,231
Number of retired or separated participants receiving benefits 2013-01-01 642
Total of all active and inactive participants 2013-01-01 13,873
2012: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 14,698
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 13,590
Number of retired or separated participants receiving benefits 2012-01-01 1,144
Number of other retired or separated participants entitled to future benefits 2012-01-01 0
Total of all active and inactive participants 2012-01-01 14,734
2011: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 16,272
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 15,222
Number of retired or separated participants receiving benefits 2011-01-01 1,392
Number of other retired or separated participants entitled to future benefits 2011-01-01 0
Total of all active and inactive participants 2011-01-01 16,614

Measure	Date	Value
2016: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	1
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	0
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	0
Total of all active and inactive participants	2016-01-01	0
2015: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	14,432
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	0
Number of retired or separated participants receiving benefits	2015-01-01	1
Number of other retired or separated participants entitled to future benefits	2015-01-01	0
Total of all active and inactive participants	2015-01-01	1
2014: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	13,873
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	14,373
Number of retired or separated participants receiving benefits	2014-01-01	59
Number of other retired or separated participants entitled to future benefits	2014-01-01	0
Total of all active and inactive participants	2014-01-01	14,432
2013: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	12,355
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	13,231
Number of retired or separated participants receiving benefits	2013-01-01	642
Total of all active and inactive participants	2013-01-01	13,873
2012: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	14,698
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	13,590
Number of retired or separated participants receiving benefits	2012-01-01	1,144
Number of other retired or separated participants entitled to future benefits	2012-01-01	0
Total of all active and inactive participants	2012-01-01	14,734
2011: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	16,272
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	15,222
Number of retired or separated participants receiving benefits	2011-01-01	1,392
Number of other retired or separated participants entitled to future benefits	2011-01-01	0
Total of all active and inactive participants	2011-01-01	16,614

Form 5500 Responses for GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN

2016: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	Yes
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – General assets of the sponsor	Yes
2016-01-01	Plan benefit arrangement – General assets of the sponsor	Yes
2015: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – General assets of the sponsor	Yes
2015-01-01	Plan benefit arrangement – General assets of the sponsor	Yes
2014: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – General assets of the sponsor	Yes
2014-01-01	Plan benefit arrangement – General assets of the sponsor	Yes
2013: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – General assets of the sponsor	Yes
2013-01-01	Plan benefit arrangement – General assets of the sponsor	Yes
2012: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – General assets of the sponsor	Yes
2012-01-01	Plan benefit arrangement – General assets of the sponsor	Yes
2011: GENENTECH/ROCHE PHARMA U.S. SPECIAL ENHANCED SEVERANCE PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	First time form 5500 has been submitted	Yes
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – General assets of the sponsor	Yes
2011-01-01	Plan benefit arrangement – General assets of the sponsor	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	GENENTECH, INC.
Employer identification number (EIN):	942347624
NAIC Classification:	325410